लोड हो रहा है...

A pharmacokinetic and pharmacodynamic drug interaction between rosuvastatin and valsartan in healthy subjects

PURPOSE: Valsartan, an angiotensin-receptor blocker, and rosuvastatin, a competitive inhibitor of the 3-hydroxy-3-methylglutaryl coenzyme A reductase, are frequently coadministered to treat patients with hypertension and dyslipidemia. The study reported here sought to evaluate the pharmacokinetic an...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Drug Des Devel Ther
मुख्य लेखकों: Jung, Jin Ah, Lee, Soo-Yun, Kim, Jung-Ryul, Ko, Jae-Wook, Jang, Seong Bok, Nam, Su Youn, Huh, Wooseong
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Dove Medical Press 2015
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4354399/
https://ncbi.nlm.nih.gov/pubmed/25767372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S76942
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!